Inflammatory Markers in Exhaled Breath Condensates From Asthmatic Patients

This study aims to compare the inflammatory mediators in exhaled breathe condensates from allergic and non-allergic asthmatic patients.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Asthma Bronchial Diseases Hypersensitivity Hypersensitivity, Immediate Immune System Diseases Lung Diseases Lung Diseases, Obstructive Respiratory Hypersensitivity Respiratory Tract Diseases

Age range

15 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Chulalongkorn University

Bangkok, 10330, Thailand

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Have been diagnosed as asthma at least 6 months before enrolled to the study
Known skin prick test results to aeroallergens ; either positive or negative
15-65 years of age

Exclusion criteria

On oral or inhaled corticosteroids within 1 month before the study
Having asthma exacerbation
Being pregnant
Suffering from severe systemic disease/ in bad health

Treatment and study plan

Primary outcomes

Levels of inflammatory cytokines in exhaled breathe condensates

Time frame: 4 months

Sponsors and collaborators

Lead sponsor

Chulalongkorn University

Other

Collaborators

Mahidol University

Registry information

Important dates

Study start: 2010
Primary completion: 2010
Study completion: 2010
First posted: Nov 23, 2010
Registry last updated: Nov 23, 2010

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed